Available Cornell Technologies
- Novel Method for the Generation, Expansion, and Maintenance of Type-1 Regulatory T Cells
- Engineered sphingosine 1-phosphate (S1P) chaperone protein compositions and methods for treating vascular and non-vascular diseases and conditions
- Combination Cancer Therapy Involving the Chronic Use of Low Doses of ATR Signaling Inhibitors
- Raspberry 'Crimson Treasure'
- Multiplex Diagnostic Test for Equine Herpes Virus Type 1
- Treatment of Cardiac Disorder with Nicotinamide Riboside
Licensing
CTL is industry's link to Cornell's broad range of innovative research that is available for licensing. Over the years, Cornell technologies have been licensed to industry partners all over the world. In support of Cornell's land-grant mission and to develop these technologies and plant varieties into products and services for public good.
Tweets by @Cornell_CTL
Like CTL on Facebook
Like CTL on Facebook for a timeline of updates about Cornell Startups and products based on licensed Cornell technologies.
Plant Varieties at Cornell
|
|